BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

ALZA Corporation

ALZA Corporation is the leading provider of drug delivery solutions with the world's broadest array of technology platforms, including oral, transdermal, implantable and liposomal technologies. ALZA partners with pharmaceutical and biotechnology companies to develop and manufacture pharmaceutical products that enhance healthcare for millions of patients worldwide.

ALZA's drug delivery platforms are designed to provide numerous benefits:



Improve efficacy and patient compliance

Reduce side effects

Enhance delivery of compounds with poor solubility or high first-pass metabolism

Address delivery challenges posed by proteins, vaccines, oligonucleotides and biopharmaceuticals

Create unique delivery profiles that meet specific drug therapy requirements


Contact Details:
1900 Charleston Road, P.O. Box 7210
Mountain View
CA
94039-7210
United States of America
Tel:(650) 564-5000
Fax: (650) 564-7070
Email:
WWW:

www.alza.com/




Loading...

Recent Publications by ALZA Corporation:

In vitro cytotoxicity of eight beta-blockers in human corneal epithelial and retinal pigment epithelial cell lines: comparison with epidermal keratinocytes and dermal fibroblasts.
beta-Blockers are a class of agents that have been used extensively in...
26th July, 2008
ALZA Corporation, Drug Device R&D, 1900 Charleston Road, Mountain View, CA Toxicol In Vitro. 2008 Jun;22(4):1070-6. Epub 2008 Feb 2.
DOI Direct Link
Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Nanoparticle dispersion has demonstrated its effectiveness in improving...
25th June, 2008
Department of Analytical Development, 1010 Joaquin Road, M4-2A, ALZA Int J Pharm. 2008 Mar 3;351(1-2):236-43. Epub 2007 Oct 10.
DOI Direct Link
Method for screening of solid dispersion formulations of low-solubility compounds--miniaturization and automation of solvent casting and dissolution testing.
An efficient method has been developed for screening solid dispersion...
25th June, 2008
Oral Products R&D, ALZA Corporation, 1015 Joaquin Road, Mountain View, CA, Int J Pharm. 2008 Mar 3;351(1-2):209-18. Epub 2007 Oct 9.
DOI Direct Link
Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
Development of solubility-enhancing formulations for poorly water-soluble...
28th May, 2008
Pharmaceutical Development, ALZA Corporation, 1900 Charleston Road, Adv Drug Deliv Rev. 2008 Mar 17;60(6):657-72. Epub 2007 Nov 9.
DOI Direct Link
Pharmacokinetic study of dexamethasone disodium phosphate using intravitreal, subconjunctival, and intravenous delivery routes in rabbits.
Dexamethasone is a corticosteroid with proven efficacy for treating both...
15th May, 2008
ALZA Corporation, Drug Device R&D, Mountain View, CA 94043, USA. J Ocul Pharmacol Ther. 2008 Jun;24(3):301-8.
DOI Direct Link

View more ALZA Corporation research publications.

BioNews Results for ALZA Corporation:

Thomson Reuters names five most promising Q1 drugs
Medical Marketing And Media:  Aug 20 2008 12:10AM Matching: alza
The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter o
Press Trust of India:  Aug 19 2008 3:26PM Matching: alza
The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter o
KRON4:  Aug 19 2008 12:34AM Matching: alza
The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter o
KOTA Territory News:  Aug 19 2008 12:02AM Matching: alza
Watson Voluntarily Recalls Pain Patch Lot
FDA News:  Aug 18 2008 10:24PM Matching: alza
Promote your company here: BioNewsCast - Press Release Distribution

View more ALZA Corporation news.

ALZA Corporation Patents:

US Patent No.Title
7005140 Lipid particles having asymmetric lipid coating and method of preparing same
7097631 Self-actuating applicator for microprojection array
7097634 Injection device providing automatic needle retraction
7108863 Liposome composition for improved intracellular delivery of a therapeutic agent
7112335 Minimally compliant, volume-efficient piston for osmotic drug delivery systems

View more ALZA Corporation patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 42 individuals from ALZA Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 773 times since April 2007, the link to the organisation's website has been followed 85 times

Recent Search Terms used to find this page: alza.com | ALZA.com | alza.com | alza corporation de | Alza Corporation DE | ALZA corporation | alza.com | alza.com | alza.com | alza.com | .

Search for more companies in Mountain View

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ALZA Corporation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.